Phase II trial of esorubicin in patients with advanced non-small cell lung cancer.

M. G. Kris, Richard J. Gralla, M. T. Burke, J. J. Fiore, D. P. Kelsen, L. D. Marks, R. T. Heelan

Research output: Contribution to journalArticle

5 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)783-784
Number of pages2
JournalCancer Treatment Reports
Volume71
Issue number7-8
StatePublished - Jul 1987
Externally publishedYes

Fingerprint

Bone Neoplasms
Drug Evaluation
Neoplasm Staging
Non-Small Cell Lung Carcinoma
Doxorubicin
Lung Neoplasms
esorubicin

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Kris, M. G., Gralla, R. J., Burke, M. T., Fiore, J. J., Kelsen, D. P., Marks, L. D., & Heelan, R. T. (1987). Phase II trial of esorubicin in patients with advanced non-small cell lung cancer. Cancer Treatment Reports, 71(7-8), 783-784.

Phase II trial of esorubicin in patients with advanced non-small cell lung cancer. / Kris, M. G.; Gralla, Richard J.; Burke, M. T.; Fiore, J. J.; Kelsen, D. P.; Marks, L. D.; Heelan, R. T.

In: Cancer Treatment Reports, Vol. 71, No. 7-8, 07.1987, p. 783-784.

Research output: Contribution to journalArticle

Kris, MG, Gralla, RJ, Burke, MT, Fiore, JJ, Kelsen, DP, Marks, LD & Heelan, RT 1987, 'Phase II trial of esorubicin in patients with advanced non-small cell lung cancer.', Cancer Treatment Reports, vol. 71, no. 7-8, pp. 783-784.
Kris MG, Gralla RJ, Burke MT, Fiore JJ, Kelsen DP, Marks LD et al. Phase II trial of esorubicin in patients with advanced non-small cell lung cancer. Cancer Treatment Reports. 1987 Jul;71(7-8):783-784.
Kris, M. G. ; Gralla, Richard J. ; Burke, M. T. ; Fiore, J. J. ; Kelsen, D. P. ; Marks, L. D. ; Heelan, R. T. / Phase II trial of esorubicin in patients with advanced non-small cell lung cancer. In: Cancer Treatment Reports. 1987 ; Vol. 71, No. 7-8. pp. 783-784.
@article{be6a6226ab054559992e3ee2d85d912a,
title = "Phase II trial of esorubicin in patients with advanced non-small cell lung cancer.",
author = "Kris, {M. G.} and Gralla, {Richard J.} and Burke, {M. T.} and Fiore, {J. J.} and Kelsen, {D. P.} and Marks, {L. D.} and Heelan, {R. T.}",
year = "1987",
month = "7",
language = "English (US)",
volume = "71",
pages = "783--784",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "7-8",

}

TY - JOUR

T1 - Phase II trial of esorubicin in patients with advanced non-small cell lung cancer.

AU - Kris, M. G.

AU - Gralla, Richard J.

AU - Burke, M. T.

AU - Fiore, J. J.

AU - Kelsen, D. P.

AU - Marks, L. D.

AU - Heelan, R. T.

PY - 1987/7

Y1 - 1987/7

UR - http://www.scopus.com/inward/record.url?scp=0023372333&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023372333&partnerID=8YFLogxK

M3 - Article

C2 - 3038319

AN - SCOPUS:0023372333

VL - 71

SP - 783

EP - 784

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 7-8

ER -